#;5L>}T!R)6]@:LT%F~]DY~.}/':=
SYSTEM PROCESSING...
#;5L>}T!R)6]@:LT%F~]DY~.}/':=
SYSTEM PROCESSING...
Posted: 2025-05-30 10:55:49 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-30 10:56:31 UTC
Verified By
Rollup News
Observational analyses suggest GLP-1 receptor agonists may reduce Alzheimer’s risk, but these findings require confirmation through randomized phase 3 trials.
Potential reduced risk of Alzheimer’s with GLP-1 receptor agonists
Need for confirmation in randomized phase 3 trials
Findings need confirmation in randomized phase 3 trials